OCULUS INC. financial data

Symbol
OVTZ on OTC
Location
Vancouver
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 63.5 % -60.1%
Return On Assets -1,038 % -1.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91,422,569 shares 0%
Common Stock, Shares, Outstanding 91,422,569 shares 0%
Entity Public Float 4,000,000 USD 0%
Common Stock, Value, Issued 46,850,710 USD 0%
Weighted Average Number of Shares Outstanding, Basic 91,422,569 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 1,476 USD -82.7%
General and Administrative Expense 111,184 USD +72.8%
Costs and Expenses 343,290 USD +3.4%
Net Income (Loss) Attributable to Parent -343,181 USD -4.8%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15,229 USD +3.4%
Assets 25,240 USD +51.9%
Accounts Payable, Current 265,114 USD +2.1%
Liabilities, Current 692,476 USD +1.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -31,177 USD +5.1%
Retained Earnings (Accumulated Deficit) -48,961,757 USD -0.71%
Stockholders' Equity Attributable to Parent -667,236 USD -1.1%
Liabilities and Equity 25,240 USD +51.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3,286 USD +94.6%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 91,422,569 shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3,624 USD +94.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 7,113,000 USD -0.5%
Deferred Tax Assets, Gross 7,113,000 USD -0.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -350,499 USD -8%
Deferred Tax Assets, Operating Loss Carryforwards 6,934,000 USD -0.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 250,000,000 shares 0%
Additional Paid in Capital 1,485,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares